Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.

Am J Hematol 2019 Jul 1;94(7):E185-E188. Epub 2019 May 1.

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25489
Publisher Site
http://dx.doi.org/10.1002/ajh.25489DOI Listing
July 2019
4 Reads

Publication Analysis

Top Keywords

lymphomas myeloproliferative
4
myeloproliferative neoplasms
4
b-cell lymphomas
4
risk b-cell
4
ruxolitinib treatment
4
treatment risk
4
neoplasms
1
ruxolitinib
1
risk
1
myeloproliferative
1
b-cell
1
lymphomas
1

Similar Publications